NIH, FDA seek lessons from hepatitis B drug trial deaths

Article Abstract:

Investigators from the Food and Drug Administration and the National Institutes of Health are looking into the deaths of two patients in a trial of Fialuridine for hepatitis B treatment. Trial managers and representatives for drug maker Eli Lilly met with officials the week of Jun 15, 1993 to discuss the trials, and possibly implications for the design of antiviral trials in general. Investigators say it is too soon to ban trials on this class of drugs.

Medicinals and botanicals, Drugs, Investigations, Testing, Eli Lilly and Co., United States. National Institutes of Health, Antiviral agents, LLY, United States. Food and Drug Administration

---

Ticking the right boxes

Article Abstract:

The reading-based Evolutec holds patent rights on a number of protein found in the saliva of ticks, with some already showing clinical promise, particularly for the treatment of allergies and inflammatory. The proteins' potency derived from a tick's need to evade detection while it feeds on its animal host with its saliva containing a number of molecules that suppress its victims immune response, allowing the tick to for days unnoticed.

United Kingdom, Science & research, Patents & copyrights, Research, Intellectual property, Evolutec Ltd.

---

Drug firms back-pedal on direct advertising

Article Abstract:

Pharmaceutical industry in the US has cut down on direct-to-consumer marketing of newly approved drugs to the public. This move by US drug companies is aimed at spending time to educate healthcare professionals about the drugs before an ad campaign begins.

United States, Legal issues & crime, Government regulation (cont), Marketing procedures, Government regulation, Direct Marketing, Direct Marketing Services, Direct Mail Advertising, Legal/Government Regulation, Other Direct Selling Establishments, Direct mail advertising services, Direct selling establishments, Direct Sales Organizations, Laws, regulations and rules, Marketing, Company marketing practices

Similar abstracts:

• Abstracts: NIH plans to begin AIDS drug trials at earlier stage. Dispute over money may foil US AIDS vaccines trial. Physicians not fazed by AZT guidelines
• Abstracts: Verdict in French blood trial shames science. Uproar greets new blood scandal indictment. French appeal court sends Allain to jail

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.